000 01148 a2200337 4500
005 20250516085005.0
264 0 _c20130619
008 201306s 0 0 eng d
022 _a1029-2403
024 7 _a10.3109/10428194.2012.682313
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNovak, Jan
245 0 0 _aRituximab-induced coagulopathy.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cNov 2012
300 _a2299-301 p.
_bdigital
500 _aPublication Type: Case Reports; Letter; Review
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xadverse effects
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBlood Coagulation Disorders
_xchemically induced
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aRituximab
650 0 4 _aWaldenstrom Macroglobulinemia
_xdrug therapy
700 1 _aMocikova, Heidi
700 1 _aPavlicek, Petr
700 1 _aGaherova, Lubica
700 1 _aKozak, Tomas
773 0 _tLeukemia & lymphoma
_gvol. 53
_gno. 11
_gp. 2299-301
856 4 0 _uhttps://doi.org/10.3109/10428194.2012.682313
_zAvailable from publisher's website
999 _c21682367
_d21682367